Amgen Inc.

AMGN.VI·Vienna·Healthcare
Compare
415.20+1.25 (+0.30%)today
As of Nov 11, 3:30 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.

Key statistics

Previous close413.95
Open413.95
Day range413.95415.65
52-week range268.70429.15
Off day high−0.11%
Off 52-week high−3.25%
Volume0.00
Avg. volume (3M)34.00
Market cap224.59B
EPS (TTM)14.85
Forward P/E—
P/E ratio (TTM)27.96
Dividend yield2.17% (8.98)
Beta (5Y)0.42
Shares outstanding540.91M
Short interest—
Earnings dateFeb 2, 2027 (est.)
Analyst target—
Profit margin24.14%

Against its peers

Compare in full ›
AMGN.VI BIIB NVS 0R1F.IL REGN GLENMARK.NS
Market cap 224.59B 37.40B 301.68B 133.94B 97.44B 755.57B
P/E (TTM) 28.0 109.5 30.5 16.8 20.8 52.1
Forward P/E — 15.6 16.0 — 13.3 27.8
Price/book 17.6 2.0 8.1 4.1 2.8 6.7
Dividend yield 2.17% — 2.90% 4.04% 0.41% 0.19%
1-year change +40.99% +56.83% +23.41% +26.24% +34.37% +44.56%
Today +0.30% −0.10% −2.16% 0.00% +2.82% +0.23%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All AMGN.VI news ›
Markets Daily·

Amgen Inc. $AMGN Stock Acquired by Leuthold Group LLC

Posted by Danessa Lincoln on Nov 10th, 2026 Leuthold Group LLC increased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,409…

The Globe and Mail·Negative

Amgen (AMGN) Receives a Buy from Scotiabank

Scotiabank analyst Louise Chen maintained a Buy rating on Amgen today and set a price target of $530.00. According to TipRanks, Chen is a 5-star analyst with an average return of 9.2% and a 54.39% success rate. Chen covers the Healthcare…

The Globe and Mail·Negative

Amgen (AMGN) Gets a Hold from Guggenheim

In a report released yesterday, Vamil Divan from Guggenheim maintained a Hold rating on Amgen, with a price target of $435.00. The company’s shares closed yesterday at $478.48. According to TipRanks, Divan is a 5-star analyst with an…

MarketScreener·Positive

Transcript : PepGen Inc. - Special Call

Presentation Operator Message Operator Welcome to the PepGen conference call to discuss top line results from lowest dose MAD cohort in the Phase II FREEDOM2 study, demonstrating promising safety,... Transcript : PepGen Inc. - Special Call…

Iceland Review·Positive

Icelandic Genetics Helped Shape Amgen’s MariTide Drug

According to the company, the work identified naturally occurring genetic signals around the GIP receptor. This strengthened the case for a drug designed to block that pathway while activating GLP-1. Amgen’s account says the turning point…

From the 4Search news index, newest first.

In the news

271mentions in 30 days
241with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance